This bill expands Maryland's child abuse reporting requirements by explicitly including female genital mutilation in the legal definition of abuse, which directly affects healthcare providers, educators, and other mandated reporters. It mandates that these professionals report suspected cases of female genital mutilation to authorities and increases penalties for violations while allowing individuals subjected to the procedure to file civil lawsuits for relief. The legislation also requires the Maryland Department of Health to create and distribute educational materials about female genital mutilation in partnership with various public and private organizations. Additionally, the bill authorizes health licensing boards to revoke licenses of individuals who commit violations related to female genital mutilation under specific circumstances.
HB 1094 requires Maryland health insurers to reimburse individuals for services provided by graduate-level clinical interns in counseling, social work, and psychology under specific conditions. It applies to insureds covered by policies meeting Maryland’s jurisdictional requirements (e.g., issued in-state or covering Maryland residents). Reimbursement is mandated only when interns work under direct supervision of licensed professionals at outpatient facilities and services are billed by the supervising clinician. The bill amends existing insurance codes to ensure coverage for these supervised intern services, directly affecting insurers, interns, and patients seeking mental health care.
HB 1389 updates Maryland law to explicitly include female genital mutilation (FGM) under the legal definition of "abuse" for child protection purposes. This requires healthcare workers, educators, and others to report suspected FGM cases - just like other forms of child abuse - and increases penalties for violations. The bill also allows victims to file civil lawsuits and mandates the Maryland Department of Health to create educational materials about FGM. These changes directly affect mandated reporters, medical professionals, and individuals at risk of FGM.
HB 1002 prohibits nursing facilities from involuntarily discharging or transferring residents to temporary housing (like hotels) without confirmation from the receiving facility that it can accept the resident. It requires facilities to provide residents with clear written notices at least 10 days before a discharge or transfer, including the reason, new location, and contact information for hearings. The bill also bans facilities from discharging Medicaid-eligible residents solely because they qualify for Medicaid benefits, and mandates that post-discharge plans include specific care details. These changes aim to protect residents' rights and ensure smoother transitions during involuntary moves.
SB 493 prohibits nursing facilities in Maryland from involuntarily discharging or transferring residents except for specific reasons like the resident's welfare, health improvement, or facility closure. It requires facilities to provide residents with a clear written notice at least 10 days before any involuntary discharge or transfer, detailing the reason, new location, and contact information for hearings and legal assistance. The bill also bans sending residents to temporary housing (like hotels) without confirmation from the receiving facility and prevents facilities from discharging Medicaid-eligible residents solely because they qualify for Medicaid. These changes aim to protect vulnerable residents by ensuring proper notice, preventing unfair treatment, and requiring confirmation before transfers.
HB 838 repeals a requirement that prescribers submit prescriber-pharmacist agreements to their regulating health board. Instead, it allows pharmacists (with specific qualifications, registrations, and training) to directly enter agreements authorizing them to treat opioid use disorder using controlled substances. A key provision requires pharmacists to check the Prescription Drug Monitoring Program (PDMP) for relevant patient data before starting or changing such therapy. This bill directly affects pharmacists, prescribers, and patients with opioid use disorder by expanding pharmacists' role in medication management under defined safeguards.
SB 562 allows pharmacists in Maryland to treat opioid use disorders using medication therapy under specific conditions. It repeals a requirement that prescribers (like doctors) must submit agreements to their health board and instead authorizes pharmacists to enter into prescriber-pharmacist agreements if they meet qualifications such as holding a Doctor of Pharmacy degree, completing required training, and registering with federal agencies. The law mandates that any treatment protocol requires pharmacists to check the Prescription Drug Monitoring Program before starting or changing medication. This change aims to expand access to medication-based treatment for opioid use disorders by enabling pharmacists to provide care in pharmacy settings.
This bill modifies when health coverage starts for small business employees enrolling during special periods (like marriage, divorce, birth, or court orders). It allows SHOP Exchanges to let employees choose whether coverage begins the next month or the month after, based on when they submit their plan selection (first half of month = next month start; second half = two months later). This directly affects Maryland small businesses using SHOP Exchange plans and their employees who qualify for these special enrollment events. The change applies specifically to enrollments triggered by court orders, death, or divorce/separation. The bill takes effect October 1, 2026.
SB 14 adjusts when health coverage becomes effective for small businesses using Maryland's SHOP Exchange during specific special enrollment periods. It allows SHOP Exchanges to set coverage start dates based on when plan selections are received: the first day of the following month if received by the 15th, or the second month if received after the 15th. This applies to enrollments triggered by court-ordered dependents (like child support), death of an employee or dependent, or divorce/legal separation. The bill directly affects small employers and their employees/dependents who qualify for these special enrollment scenarios under Maryland's SHOP program. It takes effect October 1, 2026.
SB 139 amends Maryland law to strengthen oversight of third-party administrators (TPAs) who manage insurance claims for employers or insurers. It expands grounds for the Insurance Commissioner to deny, suspend, or revoke a TPA’s registration (including violations of insurance laws or regulations) and updates civil penalty rules. The bill sets a maximum $10,000 penalty per violation for TPA misconduct, with daily penalties up to $1,000 for ongoing violations. Penalties are determined based on factors like violation severity, the TPA’s history, and harm to policyholders, ensuring enforcement considers context and impact.